|
Press Releases
| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-105 | 106-120 | 121-135
|
| |
Jan-17-2012
|
Palatin Technologies Receives $1.1 Million from Sale Of New Jersey State Tax Credits |
| |
Jan-16-2012
|
Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
|
| |
Nov-30-2011
|
Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference |
| |
Nov-15-2011
|
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
|
| |
Nov-10-2011
|
Palatin Technologies, Inc. To Report Fiscal Year 2012 First Quarter Results;
Teleconference and Webcast to be held on November 15, 2011 |
| |
Oct-21-2011
|
PALATIN TECHNOLOGIES TO PRESENT AT 10TH ANNUAL BIO INVESTOR FORUM |
| |
Sep-22-2011
|
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
|
| |
Sep-19-2011
|
Palatin Technologies, Inc. To Report Fiscal Year 2011 Fourth Quarter Results;
Teleconference and Webcast to be held on September 22, 2011 |
| |
Sep-09-2011
|
Palatin Technologies, Inc. to Present at the
Rodman & Renshaw Annual Global Investment Conference
|
| |
Aug-04-2011
|
Palatin announces commencement of a Phase 1 Trial for Obesity Compound in collaboration with AstraZeneca |
| |
Jun-28-2011
|
Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial with Bremelanotide in Women with Female Sexual Dysfunction
|
| |
Jun-23-2011
|
Alan Dunton, M.D., Joins Board of Directors
of Palatin Technologies, Inc. |
| |
Jun-21-2011
|
Palatin Technologies, Inc. Issued U.S. Patent for
Key Component in PL-3994 Drug Candidate |
| |
Jun-15-2011
|
Palatin Technologies, Inc. Announces
Presentation and Publication on Validation of Scale for
Subjective Male Sexual Arousal |
| |
May-16-2011
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results |
| |
 |
|
|
